VaccineEthics.org - The Ethical Challenges of Vaccines: FDA approves 2006-2007 flu vaccines

Thursday, August 03, 2006

FDA approves 2006-2007 flu vaccines

News from Washington yesterday that the FDA approved the vaccines to be used for the upcoming flu season. Here's the FDA press release and AP story regarding the announcement.

These approvals are an annual occurrence, as manufacturers produce flu vaccines including the specific strains of the virus recommended by WHO and FDA. There are four vaccines available:

Fluvirin (Novartis Vaccines, formerly Chiron)
Fluarix (GSK)
Fluzone (Sanofi Pasteur)
FluMist (Medimmune)

FluMist is the increasingly popular nasally-administered vaccine, the other three are injected (and few patients know which of the three they receive). In total, the FDA estimates a supply of approximately 100 million doses in the U.S. for the season.

Labels: FDA, GSK, Novartis, Sanofi, Seasonal flu

Thursday, August 03, 2006

FDA approves 2006-2007 flu vaccines

Search the Blog

Recent Posts

Archives

Editor

Subscribe via e-mail


		blog.VaccineEthics.org Vaccine News and Commentary from the University of Pennsylvania Center for Bioethics Thursday, August 03, 2006 FDA approves 2006-2007 flu vaccines News from Washington yesterday that the FDA approved the vaccines to be used for the upcoming flu season. Here's the FDA press release and AP story regarding the announcement. These approvals are an annual occurrence, as manufacturers produce flu vaccines including the specific strains of the virus recommended by WHO and FDA. There are four vaccines available: Fluvirin (Novartis Vaccines, formerly Chiron) Fluarix (GSK) Fluzone (Sanofi Pasteur) FluMist (Medimmune) FluMist is the increasingly popular nasally-administered vaccine, the other three are injected (and few patients know which of the three they receive). In total, the FDA estimates a supply of approximately 100 million doses in the U.S. for the season. Labels: FDA, GSK, Novartis, Sanofi, Seasonal flu posted by J. Schwartz at 10:26 AM Search the Blog Recent Posts June ACIP presentations available online Good news for GSK bird flu vaccine development Los Angeles school district planning to offer Gard... Gates gives $287 million for HIV vaccine research Novartis to build first U.S. cell-culture flu vacc... Two cautionary views on Gardasil Newark Star-Ledger chronicles HIV vaccine efforts A first-person perspective on the potential impact... How to make global bird flu vaccination efforts fe... Follow-up on ACIP Gardasil recommendation Archives February 2006 March 2006 April 2006 May 2006 June 2006 July 2006 August 2006 September 2006 October 2006 November 2006 December 2006 January 2007 February 2007 March 2007 April 2007 May 2007 June 2007 July 2007 September 2007 October 2007 November 2007 January 2008 February 2008 March 2008 April 2008 June 2008 July 2008 August 2008 October 2008 Editor Jason L. Schwartz Subscribe via e-mail Powered by FeedBlitz feeds.feedburner.com/vaccineethics
		Site Notice \| Contact Us \| University of Pennsylvania \| Penn Center for Bioethics © 2005—2009, University of Pennsylvania Center for Bioethics. 3401 Market Street, Suite 320, Philadelphia, PA 19104 215-898-7136 VaccineEthics.org is supported by a grant from The Greenwall Foundation.